BBAGF News Today: Stay Updated with the Latest BB Biotech AG News in Real Time
Find BBAGF news now at Meyka AI. Stay informed with the latest{" "} BB Biotech AG stocks updates, including price news, market analysis, and expert insights.
Parabilis Medicines Targets Up to $2.3 Billion Valuation in Expanded U.S. IPO Amid Biotech Market Rally
Parabilis Medicines is aiming for a valuation of nearly $2.3 billion through an expanded U.S. initial public offering, highlighting renewed investor confidence in the biotechnology sector. The Cambridge, Massachusetts-based company increased the size of its offering as demand for biotech IPOs continues to improve following a challenging period for the industry. The company now plans…
GSK to Buy Nuvalent for $10.6 Billion, Paying $124 Per Share in All-Cash Deal
GSK has made a major move in the global pharmaceutical industry. The company has agreed to acquire Nuvalent for $10.6 billion in an all-cash deal. The offer price is $124 per share, which is about a 40% premium compared to the last closing price of Nuvalent. This is not a small deal. It is one…
Panacea Biotec Soars 11.89% to 52-Week High After Launch of EU-Funded DENSTAR Project
Panacea Biotec is having its best week in years. The stock surged 11.89% to a fresh 52-week high of ₹619.05 on June 9, 2026, on the NSE, rallying from a 52-week low of ₹293.10, for an 111% climb in under twelve months. The trigger was the official launch of the DENSTAR project, a 48-month, EU-backed…
TPG Capital Boss Arrested After Refusing Breath Tests, June 04
TPG Capital co-head Joel Thickins arrested after BMW crash into five cars and refusing breath tests in Sydney. Court date: June 30.
Hang Seng Index Eyes 28,000 as Analysts Favor AI and Healthcare
Everbright Securities targets Hang Seng Index at 28,000 points in H2 2026, favoring AI, healthcare, and consumer stocks amid China’s policy support.
Abivax Shares Plunge 32% Despite Positive Colitis Trial Results Amid Safety Concerns
French biotech company Abivax delivered some of the strongest ulcerative colitis trial results seen in recent years. Yet, Abivax Shares (ABVX) plunged more than 32% on June 2, 2026, as investors focused on safety concerns rather than efficacy data. The selloff came after the company released positive Phase 3 maintenance trial results for its lead…
Eli Lilly And Co Hits $1,065 as UBS Highlights 28% Weight Loss Results From Retatrutide Study
Eli Lilly and Company has reached a major milestone as its stock price climbed to $1,065.00, driven by renewed investor optimism following strong clinical trial results for its experimental obesity drug Retatrutide. The surge reflects growing confidence in the company’s long-term growth pipeline and its leadership in the global weight-loss drug market. The latest update…
IMMX Maintained at Buy by H.C. Wainwright, May 2026
H.C. Wainwright maintains Buy rating on IMMX, raises price target to $20 from $15 on May 22, 2026.
XOMA Downgraded to Hold from Buy at Benchmark May 22
Benchmark downgraded XOMA to Hold from Buy on May 22, 2026. Stock trades at $41.65 with mixed analyst sentiment.